These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia. Rabian F; Lengline E; Rea D Curr Hematol Malig Rep; 2019 Dec; 14(6):492-500. PubMed ID: 31760572 [TBL] [Abstract][Full Text] [Related]
12. Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia. Mathisen MS; Kantarjian HM; Cortes J; Jabbour EJ Blood Rev; 2014 Sep; 28(5):179-87. PubMed ID: 24984571 [TBL] [Abstract][Full Text] [Related]
13. Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia. Orlandi EM; Elena C; Bono E Leuk Lymphoma; 2017 Jul; 58(7):1764-1766. PubMed ID: 27892750 [No Abstract] [Full Text] [Related]